Financing ·
GeoVax signs $1M revolving loan with Bowery Consulting, appoints three lender-nominated directors
GOVXGeoVax Labs, Inc.
GeoVax Labs entered into a $1,000,000 unsecured Revolving Loan Agreement with Bowery Consulting Group Inc. bearing 12% annual interest and maturing on the first anniversary of closing. The facility is subject to the Lender’s sole discretion for drawdowns and requires the Company to pursue a Qualified Public Equity Offering of at least $5,000,000. Concurrently, five directors resigned and three lender-designated nominees—Steven Brown, Tyler O’Brien, and Manpreet Uppal—were appointed to the Board, constituting a majority. GeoVax Labs is a clinical-stage biotechnology company developing vaccines and immunotherapies for infectious diseases and cancer.